Oarsman Capital, Inc. Twist Bioscience Corp Transaction History
Oarsman Capital, Inc.
- $533 Million
- Q3 2024
A detailed history of Oarsman Capital, Inc. transactions in Twist Bioscience Corp stock. As of the latest transaction made, Oarsman Capital, Inc. holds 285 shares of TWST stock, worth $13,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
285Holding current value
$13,662% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TWST
# of Institutions
258Shares Held
66.6MCall Options Held
127KPut Options Held
45.4K-
Artisan Partners Limited Partnership Milwaukee, WI6.02MShares$289 Million0.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$269 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$260 Million0.01% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.36MShares$257 Million2.3% of portfolio
-
Invesco Ltd. Atlanta, GA3.64MShares$175 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.7B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...